Product
Berotralstat
Aliases
BCX7353, Orladeyo®
Name
Orladeyo
INN Name
Berotralstat hydrochloride
FDA Approved
Yes
1 clinical trial
1 organization
2 indications
1 document
Indication
Hereditary AngioedemaIndication
PediatricClinical trial
A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children With Hereditary Angioedema Who Are 2 to < 12 Years of AgeStatus: Active (not recruiting), Estimated PCD: 2025-07-01
Document
DailyMed Label: OrladeyoOrganization
BioCryst Pharmaceuticals Inc.